Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GeneCentric Therapeutics, Inc.

News headline image
GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Announces Publication of Clinicogenomic Results from GARNER Study in High-Risk Non-Muscle Invasive Bladder Cancer
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Announces Upcoming Presentations at the American Society of Clinical Oncology Genitourinary Cancers Symposium and Precision Medicine World Conference
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Announces Publication of New Results Showing Clinical Benefit of RNA-based Antifolate Predictive Response Signature (AF-PRS) to Guide Lung Cancer Treatment Selection
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Announces Commercial Availability of PurIST℠ Test for Pancreatic Cancer
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Initiates the Alamance Study – A Real-World Investigation of Bladder Cancer Patients Treated with FGFR Inhibitors and Other Standards of Care
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric to Present Initial Clinicogenomic Results from the GARNER High-Risk Non-Muscle Invasive Bladder Cancer Real-World Study
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric to Present Discovery and Initial Clinical Utility of a Novel RNA-Based Gene Signature That Predicts Treatment Response in Patients With Head and Neck Cancer
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Closes $7.5 Million Series B1 Financing
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Collaborates with Labcorp to Develop Novel RNA-Based Oncology Diagnostics
From GeneCentric Therapeutics, Inc.
Via Business Wire
News headline image
GeneCentric Therapeutics Announces Presentations at Upcoming American Society of Clinical Oncology (ASCO) Annual Meeting
From GeneCentric Therapeutics, Inc.
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.